Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The rash resolved after stopping ponatinib.

Ruxolitinib helped a man regrow his beard after years of hair loss.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Upadacitinib effectively treats pyoderma gangrenosum.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Gefitinib therapy can cause unusual hair growth on the nose.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

An arthritis drug helped a person with severe hair loss regrow their hair.

Ruxolitinib can cause a delayed skin reaction on the nose.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.